What is Hemochromatosis?
Hemochromatosis is a hereditary condition in which your body absorbs too much iron from the food your body is digesting. As iron is stored in the body, this can lead to serious complications such as heart problems, liver disease, and diabetes. Current treatment for hemochromatosis includes the regular removal of blood from the body to help control the iron counts in the red blood cells, and lower iron levels in the body.
Hemochromatosis Clinical Trials
Clinical research studies of Hemochromatosis are conducted at GI Alliance for patients with known diagnoses of Hemochromatosis who have not found their current treatment to be effective, or wish to contribute to research. Patients who qualify for our Hemochromatosis clinical trials may have access to possible investigational medications, receive compensation for their time, and see a board-certified physician at no cost to them.
What is the purpose of Hemochromatosis clinical trials?
Clinical trials are the method of translating the research for hemochromatosis into new medicines and treatments that can provide improved patient outcomes. The lengthiest step in conducting clinical trials is often finding participants for the trials. The purpose of conducting clinical trials for Hemochromatosis is to determine the most effective and safe treatment options, and how those might apply differently to different individuals. The outcomes of clinical trials are one of the vital considerations of the U.S. Food and Drug Administration’s drug approval process. Without FDA approval, there could be no advances in patient therapeutics.
How Do I Get Involved?
If you have Hemochromatosis and want to get involved in a clinical trial for Hemochromatosis, you should fill out the form at the top of this page, and you may be matched to a clinical trial that is right for you.